Background Retrospective analyses suggest that pulmonary embolism is ruled out by a d-
dimer level of less than 1000 ng per milliliter in patients with a low clinical pretest probability …

Background Pulmonary embolism is one of the leading causes of maternal death in the
Western world. Because of the low specificity and sensitivity of the d-dimer test, all pregnant …

Pulmonary embolism (PE) in pregnant women appears to be increasing. This could be
related in part to improved health care allowing more women with risk factors to conceive, as …

Coronavirus disease 2019 (COVID-19) is a systemic disease that can be life-threatening
involving immune and inflammatory responses, and that can result in potentially lethal …

Introduction The recently proposed YEARS algorithm was shown to safely exclude
pulmonary embolism (PE) and reduce the use of computed tomography pulmonary …

Objectives COVID-19 predisposes patients to thrombotic disease. The aim of this guidance
document is to provide Belgian health-care workers with recommendations on …

Low molecular weight heparins (LMWH) have been largely studied for their use during
pregnancy. The biology and the pharmacology of these molecules are well known and may …

Pulmonary embolism (PE) is a potentially life-threatening condition that can occur during
pregnancy and pose a significant risk to the mother and the developing fetus. It is a major …

Pulmonary embolism (PE) can present with a range of severity. Prognostic risk stratification
is important for efficacious and safe management. This second of two review articles …

We analyzed data for women who received fondaparinux for≥ 7 days during pregnancy.
The study retrospectively included women who received fondaparinux pre-, peri-and/or …